Given the current prolonged life expectancy, various pathologies affect increasingly the aging subjects. Regarding the musculoskeletal apparatus, bone fragility induces more susceptibility to fractures, often not accompanied by good ability of self-repairing, in particular when critical-size defects (CSD) occur. Currently orthopedic surgery makes use of allografting and autografting which, however, have limitations due to the scarce amount of tissue that can be taken from the donor, the possibility of disease transmission and donor site morbidity. The need to develop new solutions has pushed the field of tissue engineering (TE) research to study new scaffolds to be functionalized in order to obtain constructs capable of promoting tissue regeneration and achieve stable bone recovery over time. This investigation focuses on the most important aspect related to bone tissue regeneration: the angiogenic properties of the scaffold to be used. As an innovative solution, scleral ossicles (SOs), previously characterized as natural, biocompatible and spontaneously decellularized scaffolds used for bone repair, were tested for angiogenic potential and biocompatibility. To reach this purpose, in ovo Chorioallantoic Membrane Assay (CAM) was firstly used to test the angiogenic potential; secondly, in vivo subcutaneous implantation of SOs (in a rat model) was performed in order to assess the biocompatibility and the inflammatory response. Finally, thanks to the analysis of mass spectrometry (LCMSQE), the putative proteins responsible for the SO angiogenic properties were identified. Thus, a novel natural biomaterial is proposed, which is (i) able to induce an angiogenic response in vivo by subcutaneous implantation in a non-immunodeficient animal model, (ii) which does not induce any inflammatory response, and (iii) is useful for regenerative medicine application for the healing of bone CSD.

Scleral ossicles: Angiogenic scaffolds, a novel biomaterial for regenerative medicine applications / Checchi, M.; Bertacchini, J.; Cavani, F.; Magaro, M. S.; Reggiani Bonetti, L.; Pugliese, G. R.; Tamma, R.; Ribatti, D.; Maurel, D. B.; Palumbo, C.. - In: BIOMATERIALS SCIENCE. - ISSN 2047-4830. - 8:1(2020), pp. 413-425. [10.1039/c9bm01234f]

Scleral ossicles: Angiogenic scaffolds, a novel biomaterial for regenerative medicine applications

Checchi M.;Bertacchini J.;Cavani F.;Magaro M. S.;Reggiani Bonetti L.;Palumbo C.
2020

Abstract

Given the current prolonged life expectancy, various pathologies affect increasingly the aging subjects. Regarding the musculoskeletal apparatus, bone fragility induces more susceptibility to fractures, often not accompanied by good ability of self-repairing, in particular when critical-size defects (CSD) occur. Currently orthopedic surgery makes use of allografting and autografting which, however, have limitations due to the scarce amount of tissue that can be taken from the donor, the possibility of disease transmission and donor site morbidity. The need to develop new solutions has pushed the field of tissue engineering (TE) research to study new scaffolds to be functionalized in order to obtain constructs capable of promoting tissue regeneration and achieve stable bone recovery over time. This investigation focuses on the most important aspect related to bone tissue regeneration: the angiogenic properties of the scaffold to be used. As an innovative solution, scleral ossicles (SOs), previously characterized as natural, biocompatible and spontaneously decellularized scaffolds used for bone repair, were tested for angiogenic potential and biocompatibility. To reach this purpose, in ovo Chorioallantoic Membrane Assay (CAM) was firstly used to test the angiogenic potential; secondly, in vivo subcutaneous implantation of SOs (in a rat model) was performed in order to assess the biocompatibility and the inflammatory response. Finally, thanks to the analysis of mass spectrometry (LCMSQE), the putative proteins responsible for the SO angiogenic properties were identified. Thus, a novel natural biomaterial is proposed, which is (i) able to induce an angiogenic response in vivo by subcutaneous implantation in a non-immunodeficient animal model, (ii) which does not induce any inflammatory response, and (iii) is useful for regenerative medicine application for the healing of bone CSD.
2020
6-nov-2019
8
1
413
425
Scleral ossicles: Angiogenic scaffolds, a novel biomaterial for regenerative medicine applications / Checchi, M.; Bertacchini, J.; Cavani, F.; Magaro, M. S.; Reggiani Bonetti, L.; Pugliese, G. R.; Tamma, R.; Ribatti, D.; Maurel, D. B.; Palumbo, C.. - In: BIOMATERIALS SCIENCE. - ISSN 2047-4830. - 8:1(2020), pp. 413-425. [10.1039/c9bm01234f]
Checchi, M.; Bertacchini, J.; Cavani, F.; Magaro, M. S.; Reggiani Bonetti, L.; Pugliese, G. R.; Tamma, R.; Ribatti, D.; Maurel, D. B.; Palumbo, C....espandi
File in questo prodotto:
File Dimensione Formato  
01_checchi2019.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 4.66 MB
Formato Adobe PDF
4.66 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1187447
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact